Company Update GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Glenmark is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India